Brooks O'Neil
Stock Analyst at Lake Street
(0.79)
# 3,766
Out of 4,876 analysts
36
Total ratings
26.47%
Success rate
-18.56%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $6.37 | +213.97% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $28.58 | +50.45% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $82.57 | +33.22% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $15.07 | +99.07% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $38.50 | +84.42% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $3.41 | +193.26% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $5.45 | +156.88% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.69 | +104.89% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $13.75 | -12.73% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $30.88 | +78.11% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $11.08 | +62.45% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.67 | +36.24% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $18.94 | +295.99% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $5.94 | +102.02% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $21.99 | +18.24% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $5.18 | +768.73% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.68 | +1,520.27% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $29.95 | +325.71% | 1 | Sep 15, 2020 |
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $6.37
Upside: +213.97%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $28.58
Upside: +50.45%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $82.57
Upside: +33.22%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $15.07
Upside: +99.07%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $38.50
Upside: +84.42%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.41
Upside: +193.26%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.45
Upside: +156.88%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.69
Upside: +104.89%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $13.75
Upside: -12.73%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $30.88
Upside: +78.11%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $11.08
Upside: +62.45%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.67
Upside: +36.24%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $18.94
Upside: +295.99%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $5.94
Upside: +102.02%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $21.99
Upside: +18.24%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $5.18
Upside: +768.73%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.68
Upside: +1,520.27%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $29.95
Upside: +325.71%